Government ContextGovernment Context
ActivityRulesGrantsPress releasesHearingsBills
ViewsAgenciesTopicsOrganizationsCommitteesLegislators
PricingLog inCreate account

Table of contents

DetailsOverviewExplorer

Agency Information Collection Activities; Proposed Collection; Comment Request; Good Laboratory Practice Requirements for Nonclinical Laboratory Studies

FDA-2026-N-3532-0001Notice
Comments
3
Last activity Jun 24, 2026
Deadline
Closed on Jun 30, 2026
Closed Jun 30, 2026
Net supportiSupport minus oppose · campaigns included
-50%
-50% excluding campaigns
Document

Details

The document's own metadata, straight from the source system.

Title
Agency Information Collection Activities; Proposed Collection; Comment Request; Good Laboratory Practice Requirements for Nonclinical Laboratory Studies
Posted
Apr 30, 2026
Comment period
Apr 30, 2026 – Jun 30, 2026
Agency
Food and Drug Administration (FDA)
FR Doc
2026-08371
Topics
View on regulations.gov ↗
Analysis

Overview

What the public is saying — stance, who's commenting, and the issues they raise.

Include campaigns
Analyzed 2 of 3 comments
67%· analysis in progress

Stance breakdown

-50%
Net support
Oppose1Other1Not yet analyzed1
Aggregates include form-letter campaigns. Excluding them, net support is -50% across organic comments.

Who commented

Breakdown by commenter type.

Individual
2
Not yet analyzed
1

Comments over time

Weekly arrivals, stacked by stance.

Posted Apr 30, 2026Deadline Jun 30, 2026
Apr 27Jun 22
Support0Oppose1Other1

Support × commenter type

How each type splits across stance.

Support
Oppose
Other
Individual
0%
50%
50%

Issues raised

The docket's canonical issues. Select one to browse its comments.

Compounded glp-1 drugs1
→
Compounding pharmacy access1
→
Comments

Explorer

Every mirrored comment — filter by stance, campaign, or issue.

Filter: